Biological
Donor FMT
Donor FMT is a biological therapy with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
3
50%
Ph not_applicable
3
50%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
N/ANon-phased studies
3(50.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
6
all time
Status Distribution
Active(2)
Completed(4)
Detailed Status
Completed4
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 13 (50.0%)
N/A3 (50.0%)
Trials by Status
completed467%
recruiting233%
Recent Activity
2 active trials
Showing 5 of 6
recruitingphase_1
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
NCT04759001
completedphase_1
Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma
NCT04758507
recruitingphase_1
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
NCT05791396
completednot_applicable
Fecal Microbiota Transplantation for Parkinson's Disease
NCT03808389
completednot_applicable
Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase Inhibitors
NCT04040712
Clinical Trials (6)
Showing 6 of 6 trials
NCT04759001Phase 1
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
NCT04758507Phase 1
Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma
NCT05791396Phase 1
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
NCT03808389Not Applicable
Fecal Microbiota Transplantation for Parkinson's Disease
NCT04040712Not Applicable
Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase Inhibitors
NCT03538366Not Applicable
Fecal Microbiota Transplantation for Chronic Pouchitis
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6